the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon

September 2011

Patients often don't realize the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon.

Patients on aspirin for secondary prevention...or on aspirin plus clopidogrel for acute coronary syndrome or after a stent...sometimes stop these drugs on their own with dire consequences.

For example, stopping aspirin in patients with a prior MI leads to 4 extra MIs per 1000 patients per year.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Cardiology the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon
Statins the interaction between simvastatin (Zocor, etc) and amlodipine (Norvasc, etc)
Lice Natroba (nah-TRO-buh), a new Rx topical suspension for head lice
Psychiatry stronger warnings about Seroquel and QT prolongation
Geriatrics "START" and "STOPP" instead of Beers to evaluate appropriate med use in the elderly
Infectious Diseases new strain of ceftriaxone-resistant gonorrhea
Acetaminophen changes to OTC Tylenol and other acetaminophen products
Anticoagulants how to reverse bleeding due to Pradaxa or Xarelto
Migraine whether it's okay to use triptans (sumatriptan, etc) for migraines in CHILDREN
Parkinson's Disease treating Parkinson's disease AFTER the "honeymoon" is over
Diabetes Patients are asking about a new "bloodless" glucose meter
Edema how to handle peripheral edema due to dihydropyridine calcium channel blockers (amlodipine, etc)

the risk of stopping aspirin, clopidogrel, or other antiplatelet drugs too soon

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents